Equilliumbio
VP of Clinical Development
San Diego, California
hirly Pro
Get in front of the people hiring at Equilliumbio
- Reach the hiring manager at Equilliumbio on LinkedIn, from your own account
- hirly applies to this job for you, with unlimited applications
- A resume and cover letter written for this job, unlimited
- The hiring manager and recruiter at Equilliumbio, with contact details
$49 a month · ₹1,999 for 30 days in India · cancel any time
Get past the screening software and onto a recruiter's desk
hirly rewrites your resume for this job — matching the keywords and skills in the posting, moving your most relevant experience to the top, and writing a cover letter to fit. About 30 seconds.
- Keywords matched to this posting
- Fit score before you apply
- Cover letter included
Matched against 2M live jobs from 210,000+ employers in 190+ countries.
Tailor my resume for this job →Apply from your AI assistant
Connect hirly to Claude or ChatGPT and ask it to apply to this job. hirly tailors your resume, fills the employer’s form and asks before sending.
Some employer sites stop an application at a CAPTCHA or sign-in and hand it back with a link. Applying needs a paid plan. Works with any assistant that supports MCP.
hirly's read of this role
- Seniority
- Executive
- Country
- US
- Work mode
- On-site / unstated
- First seen by hirly
- 18 Nov 2026
Derived automatically from the posting. Upload your resume above to see how the role scores against it.
the posting
Company Overview
Equillium, Inc. (Nasdaq: EQ) is a biotechnology innovator with a mission to develop highly impactful therapies for serious autoimmune and inflammatory disorders. The company is building a focused, wholly owned pipeline of targeted therapeutics designed to address tissue inflammation and restore immune and barrier homeostasis. Equillium’s lead program, EQ504, is an investigational potent and selective aryl hydrocarbon receptor ( AhR ) modulator with a multimodal, non-immunosuppressive mechanism of action. For ulcerative colitis, EQ504 is formulated as an oral, colon-targeted, delayed-release drug product.
Position Overview
- The Vice President, Clinical Development, I&I will provide medical and strategic leadership for Equillium’s
- clinical portfolio, with primary responsibility for the clinical development of EQ504 in ulcerative colitis and pulmonary indications, as well as secondary support for EQ302 in celiac disease.
Essential Duties and Responsibilities
Lead the integrated clinical development strategy and clinical development plan for EQ504 in ulcerative colitis, including indication strategy, target product profile, evidence-generation plan, decision criteria, timelines and budgets.
Provide medical leadership for the ongoing EQ504 Phase 1 proof-of-mechanism study, including protocol execution, dose and regimen evaluation, safety monitoring, data review, interpretation and communication of results.
Lead the planning and design of a Phase 2 study in patients with ulcerative colitis to follow the Phase 1 study, including development of the protocol and statistical framework, patient population and eligibility criteria, dose and regimen selection, endpoints, biomarkers, site and country strategy, operational feasibility, budget, timelines and regulatory alignment.
Provide clinical development input for EQ302 in celiac disease.
Lead development of clinical protocols, investigator brochures, clinical study reports, clinical sections of regulatory submissions and briefing materials for health authority interactions.
Provide medical oversight of clinical trials, including eligibility and enrollment issues, protocol deviations, emerging efficacy and biomarker data, and aggregate safety assessment in partnership with Pharmacovigilance.
Guide clinical pharmacology, biomarker and translational strategies that establish proof of mechanism, support Phase 2 dose selection and strengthen the differentiation of EQ504; advise on EQ302 selectively as needed.
Contribute to portfolio, business development, financing and investor activities by clearly communicating program strategy, clinical rationale, development risks and value-creating milestones.
Key Measures of Success
High-quality execution and interpretation of the EQ504 Phase 1 program and a Phase 2 ulcerative colitis study that is designed, operationally feasible and ready to initiate following supportive Phase 1 results.
Focused, fit-for-purpose clinical development support for EQ504 pulmonary indications and EQ302 for celiac disease .
Timely delivery of clinical and regulatory milestones with disciplined risk management and transparent communication.
Strong engagement with leading gastroenterology investigators and advisors, and a compelling external scientific profile for the portfolio.
Effective cross-functional leadership that aligns strategy, operations and decision-making.
Education and Experience
M.D. or Ph.D. required .
Board certification or advanced clinical training in gastroenterology is strongly preferred.
Typically, 12 or more years of relevant biopharmaceutical clinical development experience, including meaningful leadership responsibility for I&I programs.
Demonstrated expertise in inflammatory bowel disease, particularly ulcerative colitis; experience in celiac disease , immune-mediated gastrointestinal disorders , and/or pulmonary diseases is highly desirable.
Skills and Leadership Attributes
Decisive, pragmatic, and comfortable operating hands-on in a dynamic fast-moving organization.
Strategic, collaborative, low-ego leader who creates clarity and accountability.
Ability to travel domestically and internationally up to approximately 25%.
Equal Opportunity
Equillium is an equal opportunity employer.
*This JD has been shortened. Interviewing candidates will be provided the longer version upon advancing into the interviewing process. *
Listed on hirly, a job board. hirly is not the employer: Equilliumbio is hiring for this role.
Similar jobs
- Director-Clinical DevelopmentBaptist · Memphis, TN, United StatesFirst seen 51d ago
- Clinical Development Lead, AI/LLMNeko Health · New YorkFirst seen 77d ago
- Clinical Development Lead (m/w/d)Boehringer Ingelheim Pharma GmbH & Co. KG · Ingelheim am Rhein, Rheinland-Pfalz, GermanyFirst seen 22d ago
- Director Clinical DevelopmentVERTANICAL · Gräfelfing/MunichFirst seen 47d ago
- Senior Director Early Clinical DevelopmentNovotech Global · GermanyFirst seen 50d ago
Browse similar roles
Want this one?
Upload your resume and hirly rewrites it for this job and writes the cover letter — in about thirty seconds, before you sign up.
Tailor my resume for this job